Product
AER002
1 clinical trial
3 indications
Indication
Long COVIDIndication
Post-Acute Sequela of COVID-19Indication
Post-Acute COVID-19Clinical trial
An Exploratory, Randomized, Double-Blind Placebo-Controlled Study to Assess the Safety of an Anti-SARS-CoV-2 Monoclonal Antibody and Response to Treatment in Individuals With Long COVID (outSMART-LC)Status: Active (not recruiting), Estimated PCD: 2025-07-31